Your browser doesn't support javascript.
loading
Effects of itraconazole and carbamazepine on the pharmacokinetics of nirmatrelvir/ritonavir in healthy adults.
Cox, Donna S; Van Eyck, Lien; Pawlak, Sylvester; Beckerman, Bruce; Linn, Carlos; Ginman, Katherine; Thay Cha, Youliny; LaBadie, Robert R; Shi, Haihong; Damle, Bharat.
Afiliación
  • Cox DS; Global Product Development, Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Van Eyck L; Clinical Research Unit, Pfizer Inc., Brussels, Belgium.
  • Pawlak S; Clinical Research Unit, Pfizer Inc., New Haven, Connecticut, USA.
  • Beckerman B; Clinical Development and Operations, Pfizer Inc., New York, New York, USA.
  • Linn C; Global Product Development, Pfizer Inc., Taipei, Taiwan.
  • Ginman K; Global Product Development, Pfizer Inc., Groton, Connecticut, USA.
  • Thay Cha Y; Global Product Development, Pfizer Inc., Groton, Connecticut, USA.
  • LaBadie RR; Global Product Development, Pfizer Inc., Groton, Connecticut, USA.
  • Shi H; Global Product Development, Pfizer Inc., Groton, Connecticut, USA.
  • Damle B; Global Product Development, Pfizer Inc., New York, New York, USA.
Br J Clin Pharmacol ; 89(9): 2867-2876, 2023 09.
Article en En | MEDLINE | ID: mdl-37184075

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Itraconazol / Ritonavir Tipo de estudio: Prognostic_studies Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Itraconazol / Ritonavir Tipo de estudio: Prognostic_studies Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article